| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Aminoglycoside antibiotics in infectious diseases: An overview
|
Siegenthaler, Walter E.
|
|
1986
|
80 |
6S2 |
p. 2-14
13 p.
|
artikel
|
| 2 |
Aminoglycoside resistance: a worldwide perspective
|
Young, Lowell S.
|
|
1986
|
80 |
6S2 |
p. 15-21
7 p.
|
artikel
|
| 3 |
Aminoglycosides in gynecologic infections
|
Ledger, William J.
|
|
1986
|
80 |
6S2 |
p. 216-221
6 p.
|
artikel
|
| 4 |
Aminoglycosides plus beta-lactams against gram-negative organisms: Evaluation of in vitro synergy and chemical interactions
|
Giamarellou, Helen
|
|
1986
|
80 |
6S2 |
p. 126-137
12 p.
|
artikel
|
| 5 |
Antibiotics delivered by an implantable drug pump: A new application for treating osteomyelitis
|
Perry, Clayton R.
|
|
1986
|
80 |
6S2 |
p. 222-227
6 p.
|
artikel
|
| 6 |
Antibiotics in the second half of the 1980s: Areas of future development and the effect of new agents on aminoglycoside use
|
Neu, Harold C.
|
|
1986
|
80 |
6S2 |
p. 195-203
9 p.
|
artikel
|
| 7 |
Arninoglycoside toxicity in infants and children
|
McCracken Jr., George H.
|
|
1986
|
80 |
6S2 |
p. 172-178
7 p.
|
artikel
|
| 8 |
Challenging conventional aminoglycoside dosing regimens: The value of experimental models
|
Kapusnik, Joan E.
|
|
1986
|
80 |
6S2 |
p. 179-181
3 p.
|
artikel
|
| 9 |
Choice of drug and dosage regimen: Two important risk factors for aminoglycoside nephrotoxicity
|
De Broe, Marc E.
|
|
1986
|
80 |
6S2 |
p. 115-118
4 p.
|
artikel
|
| 10 |
Coagulase-negative staphylococci as nosocomial pathogens in neonates: The role of host defense, artificial devices, and bacterial hydrophobicity
|
Fleer, Andre
|
|
1986
|
80 |
6S2 |
p. 161-165
5 p.
|
artikel
|
| 11 |
Combination antibiotic therapy in pediatrics
|
Chadwick, Ellen Gould
|
|
1986
|
80 |
6S2 |
p. 166-171
6 p.
|
artikel
|
| 12 |
Combination therapy and monotherapy in the treatment of severe infection in the immunocompromised host
|
Gaya, Harold
|
|
1986
|
80 |
6S2 |
p. 149-155
7 p.
|
artikel
|
| 13 |
Combination therapy: a way to limit emergence of resistance?
|
Michea-Hamzehpour, Mehri
|
|
1986
|
80 |
6S2 |
p. 138-142
5 p.
|
artikel
|
| 14 |
Comparative review of combination therapy: two beta-lactams versus beta-lactam plus aminoglycoside
|
Dejace, Pierre
|
|
1986
|
80 |
6S2 |
p. 29-38
10 p.
|
artikel
|
| 15 |
Comparative study of ototoxicity and nephrotoxicity in patients randomly assigned to treatment with amikacin or gentamicin
|
Lerner, Stephen A.
|
|
1986
|
80 |
6S2 |
p. 98-104
7 p.
|
artikel
|
| 16 |
Control of emergence of multi-resistant gram-negative bacilli by exclusive use of amikacin
|
Ruiz-Palacios, Guillermo M.
|
|
1986
|
80 |
6S2 |
p. 71-75
5 p.
|
artikel
|
| 17 |
Cost-effective aminoglycoside therapy in surgical patients
|
Gladen, Herbert E.
|
|
1986
|
80 |
6S2 |
p. 228-233
6 p.
|
artikel
|
| 18 |
Experimental studies on nephrotoxicity of aminoglycosides at low doses: Mechanisms and perspectives
|
Tulkens, Paul M.
|
|
1986
|
80 |
6S2 |
p. 105-114
10 p.
|
artikel
|
| 19 |
Future trends in aminoglycoside therapy
|
Levin, Stuart
|
|
1986
|
80 |
6S2 |
p. 190-194
5 p.
|
artikel
|
| 20 |
Have the new beta-lactams rendered the aminoglycosides obsolete for the treatment of serious nosocomial infections?
|
Moellering Jr., Robert C.
|
|
1986
|
80 |
6S2 |
p. 44-47
4 p.
|
artikel
|
| 21 |
Introduction
|
Moellering Jr., Robert C.
|
|
1986
|
80 |
6S2 |
p. 1-
1 p.
|
artikel
|
| 22 |
In vitro evaluations of amikacin: an assessment of the currently used methods of disk diffusion and dilution susceptibility, antimicrobial synergy, and the measurement of amikacin concentrations
|
Jones, Ronald N.
|
|
1986
|
80 |
6S2 |
p. 88-97
10 p.
|
artikel
|
| 23 |
In vitro models for the study of combination antibiotic therapy in neutropenic patients
|
Zinner, Stephen H.
|
|
1986
|
80 |
6S2 |
p. 156-160
5 p.
|
artikel
|
| 24 |
Management of intra-abdominal sepsis
|
Nichols, Ronald Lee
|
|
1986
|
80 |
6S2 |
p. 204-209
6 p.
|
artikel
|
| 25 |
Management of sepsis in the elderly
|
Holloway, William J.
|
|
1986
|
80 |
6S2 |
p. 143-148
6 p.
|
artikel
|
| 26 |
Prevalence and mechanisms of aminoglycoside resistance: A ten-year study
|
Phillips, Ian
|
|
1986
|
80 |
6S2 |
p. 48-55
8 p.
|
artikel
|
| 27 |
Publisher's note
|
|
|
1986
|
80 |
6S2 |
p. ii-
1 p.
|
artikel
|
| 28 |
Qualitative overview of randomized trials of aminoglycosides
|
Evans, Denis A.
|
|
1986
|
80 |
6S2 |
p. 39-43
5 p.
|
artikel
|
| 29 |
Resistance surveillance programs and the incidence of gram-negative bacillary resistance to amikacin from 1967 to 1985
|
Gerding, Dale N.
|
|
1986
|
80 |
6S2 |
p. 22-28
7 p.
|
artikel
|
| 30 |
Review of epidemic aminoglycoside resistance worldwide
|
Mayer, Kenneth H.
|
|
1986
|
80 |
6S2 |
p. 56-64
9 p.
|
artikel
|
| 31 |
Risk factors and comparisons of clinical nephrotoxicity of aminoglycosides
|
Meyer, Richard D.
|
|
1986
|
80 |
6S2 |
p. 119-125
7 p.
|
artikel
|
| 32 |
Strategies in aminoglycoside use and impact upon resistance
|
Acar, Jacques F.
|
|
1986
|
80 |
6S2 |
p. 82-87
6 p.
|
artikel
|
| 33 |
Surveillance of aminoglycoside resistance: European data
|
Van Landuyt, Herman W.
|
|
1986
|
80 |
6S2 |
p. 76-81
6 p.
|
artikel
|
| 34 |
Susceptibility of aerobic gram-negative bacilli to aminoglycosides: Effects of 45 months of amikacin as first-line aminoglycoside therapy
|
Saavedra, Sonia
|
|
1986
|
80 |
6S2 |
p. 65-70
6 p.
|
artikel
|
| 35 |
The potential for discovery and development of improved aminoglycosides
|
Price, Kenneth E.
|
|
1986
|
80 |
6S2 |
p. 182-189
8 p.
|
artikel
|
| 36 |
Upper and lower urinary tract infections: Amikacin's role in managing surgical complications
|
Childs, Stacy J.
|
|
1986
|
80 |
6S2 |
p. 210-215
6 p.
|
artikel
|
Tijdschrift beschrijving